Cargando…

Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens

Detalles Bibliográficos
Autores principales:	Grimm, S, Ackerman, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441900/ http://dx.doi.org/10.1186/1742-4690-9-S2-P326

Ejemplares similares

Viral vector delivery of Env trimer immunogens
por: Parks, CL, et al.
Publicado: (2012)

Development of chimeric HIV Env immunogens for mucosal delivery with attenuated canine distemper virus (CDV) vaccine vectors
por: Zhang, X, et al.
Publicado: (2012)

P04-24. Frequencies of HIV Env-specific B cells and neutralizing antibodies during DNA-prime/protein-boost immunization with three different Env immunogens*
por: Tawde, P, et al.
Publicado: (2009)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
por: Chen, Y, et al.
Publicado: (2012)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
por: Ching, LK, et al.
Publicado: (2009)

HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env
por: Li, Y, et al.
Publicado: (2012)

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
por: Pejawar-Gaddy, S, et al.
Publicado: (2012)

Display of the HIV envelope protein at the yeast cell surface for immunogen development
por: Mathew, Elizabeth, et al.
Publicado: (2018)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
por: Hulot, SL, et al.
Publicado: (2012)

2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies
por: Zhang, H, et al.
Publicado: (2012)

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
por: Yan, J, et al.
Publicado: (2012)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

Env mutations conferring improved entry efficiency allow HIV to replicate in the presence of IFN
por: Rato, Sylvie, et al.
Publicado: (2013)

Co-immunization with HIV Env DNA and protein elicit long-lasting strong cellular and humoral immune responses
por: Li, J, et al.
Publicado: (2012)

Isolation and purification of HIV-1 LTR circles from PBMCs for the analysis of episomal env sequences
por: González, Sandra, et al.
Publicado: (2006)

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
por: Wahren, B, et al.
Publicado: (2006)

Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection
por: Thobakgale, C, et al.
Publicado: (2012)

P12-02. Cell-surface display and panning of HIV-1 derived envelope proteins
por: Bruun, T, et al.
Publicado: (2009)

N-terminal foamy virus Gag domains and individual residues are critical for capsid assembly and interaction with the unique Env leader protein Elp for Env-dependent budding
por: Liu, Yang, et al.
Publicado: (2013)

P19-09. Site-specific incorporation of an unnatural amino acid into the HIV-1 Env spike
por: Arnett, SO, et al.
Publicado: (2009)

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
por: Alexander, J, et al.
Publicado: (2012)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
por: Wieczorek, L, et al.
Publicado: (2012)

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant
por: Sun, J, et al.
Publicado: (2009)

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates
por: Theis, JF, et al.
Publicado: (2012)

Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates
por: Gao, G, et al.
Publicado: (2012)

P20-08. Glycosylation: an important factor in Env diversity
por: Desaire, H, et al.
Publicado: (2009)

The C-terminal tail of HIV-1 envelope: a unique role for conserved LLP arginines in Env functional properties
por: Kuhlmann, A, et al.
Publicado: (2012)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
por: Premanand, Balraj, et al.
Publicado: (2018)

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies
por: Fuchs, JD, et al.
Publicado: (2012)

P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission
por: Peut, V, et al.
Publicado: (2009)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012)

Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012)

Development of candidate HIV vaccines using VSV vectors to express membrane-anchored MPER immunogen
por: Yuan, M, et al.
Publicado: (2012)

Fusion of CTA and CTB gene to immunogen significantly enhances the immunogenicity of DNA vaccine
por: Ren, X, et al.
Publicado: (2012)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies
por: Gorman, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r9hrn5e2pg47psp0j9hh6t90gu